The cancer survival gap between elderly and middle-aged patients in Europe is widening.

PubWeight™: 1.93‹?› | Rank: Top 3%

🔗 View Article (PMID 19121578)

Published in Eur J Cancer on December 31, 2008

Authors

Alberto Quaglia1, Andrea Tavilla, Lorraine Shack, Hermann Brenner, Maryska Janssen-Heijnen, Claudia Allemani, Marc Colonna, Enrico Grande, Pascale Grosclaude, Marina Vercelli, EUROCARE Working Group

Author Affiliations

1: Liguria Cancer Registry, National Cancer Research Institute, Genoa 16132, Italy. alberto.quaglia@istge.it

Articles citing this

Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet (2010) 11.06

Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma. Br J Cancer (2014) 2.26

A catalyst for change: the European cancer Patient's Bill of Rights. Oncologist (2014) 1.55

Socio-demographic inequalities in stage of cancer diagnosis: evidence from patients with female breast, lung, colon, rectal, prostate, renal, bladder, melanoma, ovarian and endometrial cancer. Ann Oncol (2012) 1.54

Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project. Haematologica (2011) 1.43

Tumor location and patient characteristics of colon and rectal adenocarcinomas in relation to survival and TNM classes. BMC Cancer (2010) 1.30

Variation in advanced stage at diagnosis of lung and female breast cancer in an English region 2006-2009. Br J Cancer (2012) 1.19

Are GPs under-investigating older patients presenting with symptoms of ovarian cancer? Observational study using General Practice Research Database. Br J Cancer (2010) 1.15

Epidemiology and treatment of melanoma in elderly patients. Nat Rev Clin Oncol (2010) 1.08

Squamous cell carcinoma of the head and neck in the elderly. Rep Pract Oncol Radiother (2012) 0.98

Colorectal cancer mortality in Hong Kong of China, Japan, South Korea, and Singapore. World J Gastroenterol (2013) 0.97

Chemotherapy for colorectal cancer in the elderly. World J Gastroenterol (2015) 0.93

Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study. Haematologica (2012) 0.93

Lack of survival gain for elderly women with breast cancer. Oncologist (2011) 0.91

Treatment of colorectal cancer in older patients. Nat Rev Gastroenterol Hepatol (2012) 0.89

Survival from colorectal cancer in Germany in the early 21st century. Br J Cancer (2012) 0.88

An Association of Cancer Physicians' strategy for improving services and outcomes for cancer patients. Ecancermedicalscience (2016) 0.88

Impact of age and socioeconomic status on treatment and survival from aggressive lymphoma: a UK population-based study of diffuse large B-cell lymphoma. Cancer Epidemiol (2015) 0.85

Survival of endometrial cancer patients in Germany in the early 21st century: a period analysis by age, histology, and stage. BMC Cancer (2012) 0.83

Treatment of older patients with colorectal cancer: a perspective review. Ther Adv Med Oncol (2014) 0.81

Potential for improvement in cancer management: reducing mortality in the European Union. Oncologist (2015) 0.78

Addressing cancer disparities in Europe: a multifaceted problem that requires interdisciplinary solutions. Oncologist (2013) 0.78

[Comorbidity oriented oncology - an overview]. Wien Klin Wochenschr (2010) 0.78

Age-specific cancer survival in Estonia: recent trends and data quality. Clin Epidemiol (2015) 0.77

Management of operable breast cancer in older women. J R Soc Med (2013) 0.76

Feasibility study of pelvic helical IMRT for elderly patients with endometrial cancer. PLoS One (2014) 0.76

The challenge of cancer in middle-income countries with an ageing population: Mexico as a case study. Ecancermedicalscience (2015) 0.76

The impact of eliminating age inequalities in stage at diagnosis on breast cancer survival for older women. Br J Cancer (2015) 0.76

Cancer and ageism. Ecancermedicalscience (2014) 0.75

Anticancer effect of icaritin inhibits cell growth of colon cancer through reactive oxygen species, Bcl-2 and cyclin D1/E signaling. Oncol Lett (2016) 0.75

Management of pancreatic cancer in the elderly. World J Gastroenterol (2016) 0.75

Hepatocellular carcinoma in elderly patients: challenges and solutions. J Hepatocell Carcinoma (2016) 0.75

Study populations for period analyses of cancer survival. Br J Cancer (2013) 0.75

Ovarian Cancer Management in the Oldest Old: Improving Outcomes and Tailoring Treatments. Aging Dis (2017) 0.75

Articles by these authors

Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet (2013) 8.24

Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol (2007) 8.05

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 7.99

Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat Genet (2008) 6.97

Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nat Genet (2008) 6.75

C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet (2015) 6.13

EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary. Ann Oncol (2003) 5.78

EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer (2009) 5.61

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet (2013) 5.58

Tobacco-smoking-related differential DNA methylation: 27K discovery and replication. Am J Hum Genet (2011) 5.18

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35

Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer (2003) 3.89

EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol (2003) 3.88

Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81

Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol (2002) 3.53

Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood (2010) 3.21

Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet (2012) 3.20

Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J Natl Cancer Inst (2010) 3.18

Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol (2009) 3.14

Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet (2011) 3.07

Rare cancers are not so rare: the rare cancer burden in Europe. Eur J Cancer (2011) 2.95

Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate. Clin Chem (2004) 2.95

Increased incidence of thyroid carcinoma in france: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid (2004) 2.83

Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Gastroenterology (2012) 2.57

Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004. J Natl Cancer Inst (2008) 2.56

Cancer net survival on registry data: use of the new unbiased Pohar-Perme estimator and magnitude of the bias with the classical methods. Int J Cancer (2012) 2.43

Smoking and all-cause mortality in older people: systematic review and meta-analysis. Arch Intern Med (2012) 2.42

Meta-analysis of new genome-wide association studies of colorectal cancer risk. Hum Genet (2011) 2.35

Incidence of uveal melanoma in Europe. Ophthalmology (2007) 2.30

Vitamin D and cardiovascular disease: systematic review and meta-analysis of prospective studies. Prev Med (2010) 2.27

Atherogenic dyslipidaemia but not total- and high-molecular weight adiponectin are associated with the prognostic outcome in patients with coronary heart disease. Eur Heart J (2008) 2.26

Cost-effectiveness of colorectal cancer screening. Epidemiol Rev (2011) 2.24

Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. Am J Hum Genet (2013) 2.24

Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study. J Am Coll Cardiol (2013) 2.18

Socioeconomic deprivation and cancer survival in Germany: an ecological analysis in 200 districts in Germany. Int J Cancer (2013) 2.18

Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5--a population-based study. Lancet Oncol (2013) 2.17

Effect of obesity and other lifestyle factors on mortality in women with breast cancer. Int J Cancer (2008) 2.17

Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers. Eur Heart J (2005) 2.16

Survival trends in European cancer patients diagnosed from 1988 to 1999. Eur J Cancer (2009) 2.12

Survival of European children and young adults with cancer diagnosed 1995-2002. Eur J Cancer (2009) 2.08

Childhood cancer survival trends in Europe: a EUROCARE Working Group study. J Clin Oncol (2005) 2.02

Blood markers for early detection of colorectal cancer: a systematic review. Cancer Epidemiol Biomarkers Prev (2007) 2.00

Sex hormone levels, breast cancer risk, and cancer receptor status in postmenopausal women: the ORDET cohort. Cancer Epidemiol Biomarkers Prev (2009) 1.99

Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis. Oncologist (2010) 1.94

Older smokers' motivation and attempts to quit smoking: epidemiological insight into the question of lifestyle versus addiction. Dtsch Arztebl Int (2009) 1.92

Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk. PLoS Genet (2013) 1.88

Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection. Ann Intern Med (2009) 1.84

19p13.1 is a triple-negative-specific breast cancer susceptibility locus. Cancer Res (2012) 1.81

Circulating adipocyte fatty acid-binding protein levels and cardiovascular morbidity and mortality in patients with coronary heart disease: a 10-year prospective study. Arterioscler Thromb Vasc Biol (2012) 1.80

Quality of life in patients with colorectal cancer 1 year after diagnosis compared with the general population: a population-based study. J Clin Oncol (2004) 1.80

Efficacy of a nationwide screening colonoscopy program for colorectal cancer. Gastroenterology (2012) 1.79

Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology. Eur J Cancer (2003) 1.79

Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression. Hum Mol Genet (2013) 1.78

Cross-sectional and longitudinal changes in DNA methylation with age: an epigenome-wide analysis revealing over 60 novel age-associated CpG sites. Hum Mol Genet (2013) 1.77

Cardiac troponin T measured by a high-sensitivity assay predicts recurrent cardiovascular events in stable coronary heart disease patients with 8-year follow-up. Clin Chem (2012) 1.76

Cancer survival increases in Europe, but international differences remain wide. Eur J Cancer (2001) 1.76

Relationship of adiponectin with markers of systemic inflammation, atherogenic dyslipidemia, and heart failure in patients with coronary heart disease. Clin Chem (2006) 1.75

Epigenotyping in peripheral blood cell DNA and breast cancer risk: a proof of principle study. PLoS One (2008) 1.75

Helicobacter pylori infection and colorectal cancer risk: evidence from a large population-based case-control study in Germany. Am J Epidemiol (2012) 1.74

Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease. Arch Intern Med (2006) 1.73

Colorectal cancer mortality prevented by use and attributable to nonuse of colonoscopy. Gastrointest Endosc (2011) 1.72

Time trends of breast cancer survival in Europe in relation to incidence and mortality. Int J Cancer (2006) 1.71

The performance of methods for correcting measurement error in case-control studies. Epidemiology (2002) 1.71

Meta-analysis: serum vitamin D and breast cancer risk. Eur J Cancer (2010) 1.69

A systematic review of leukocyte telomere length and age in adults. Ageing Res Rev (2013) 1.67

Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century. Blood (2008) 1.65

Calcium, phosphate and the risk of cardiovascular events and all-cause mortality in a population with stable coronary heart disease. Heart (2012) 1.64

Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study. Am J Clin Nutr (2013) 1.62

Flexible matching strategies to increase power and efficiency to detect and estimate gene-environment interactions in case-control studies. Am J Epidemiol (2002) 1.60

MicroRNA signatures: novel biomarker for colorectal cancer? Cancer Epidemiol Biomarkers Prev (2011) 1.60

Characterization of gene-environment interactions for colorectal cancer susceptibility loci. Cancer Res (2012) 1.58

Overdiagnosis from non-progressive cancer detected by screening mammography: stochastic simulation study with calibration to population based registry data. BMJ (2011) 1.58

Childhood cancer survival in Europe. Ann Oncol (2003) 1.57

Impact of national smoke-free legislation on home smoking bans: findings from the International Tobacco Control Policy Evaluation Project Europe Surveys. Tob Control (2012) 1.56

Comparative cancer survival information in Europe. Eur J Cancer (2009) 1.56

Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 1.56

Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors. PLoS Genet (2013) 1.56

Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflammation, renal function, and hemodynamic stress. Arterioscler Thromb Vasc Biol (2006) 1.56

Epidemiology of Helicobacter pylori infection. Helicobacter (2004) 1.56

Assisted reproductive techniques and risk of exstrophy-epispadias complex: a German case-control study. J Urol (2012) 1.55

Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: the EUROCARE study. Int J Cancer (2011) 1.54

Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42,103 individuals. Gut (2012) 1.52

Recurrent abdominal pain in children: evidence from a population-based study that social and familial factors play a major role but not Helicobacter pylori infection. J Psychosom Res (2003) 1.51

Smoking, F2RL3 methylation, and prognosis in stable coronary heart disease. Eur Heart J (2012) 1.51

Survival from rare cancer in adults: a population-based study. Lancet Oncol (2006) 1.49

A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. Hum Mol Genet (2012) 1.47

High-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality. Eur Heart J (2013) 1.46

Multiple tumours in survival estimates. Eur J Cancer (2009) 1.46

Long-term survival of patients diagnosed with non-Hodgkin lymphoma after a previous malignancy. Leuk Lymphoma (2009) 1.46

Conditional survival analyses across cancer sites. Health Rep (2011) 1.46

Improvement in survival of older adults with multiple myeloma: results of an updated period analysis of SEER data. Oncologist (2011) 1.45

Physical activity, coronary heart disease, and inflammatory response. Arch Intern Med (2003) 1.44